Moderna (MRNA) Gross Margin Growth (3y) (2023 - 2026)

Moderna (MRNA) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Moderna 22.52 Bn 17.32 Bn -566.00 Mn -20,297.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -20,297.00
Dec 31, 2025 -5,880.00
Sep 30, 2025 1,233.00
Jun 30, 2025 -5,472.00
Mar 31, 2025 -6,657.00
Dec 31, 2024 -6,330.00
Sep 30, 2024 -1,307.00
Jun 30, 2024 -3,049.00
Mar 31, 2024 -4,752.00
Dec 31, 2023 -3,165.00
Sep 30, 2023 -12,239.00
Jun 30, 2023 -21,250.00
Mar 31, 2023 -4,253.00